Location History:
- Ashiya, JP (2002 - 2012)
- Suita, JP (2013 - 2022)
- Osaka, JP (2022)
Company Filing History:
Years Active: 2002-2022
Title: Tomomi Makino: Innovator in Cell Culture Technology
Introduction
Tomomi Makino is a prominent inventor based in Ashiya, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of advanced cell culture substrates. With a total of 7 patents to his name, Makino's work is paving the way for innovative solutions in tissue engineering.
Latest Patents
One of his latest inventions is a cell culture substrate comprising a fluorine-containing polymer on its surface. This invention provides a substrate that enables three-dimensional tissue culture, which is crucial for various biomedical applications. The substrate features a surface that includes a resin composition made of a fluorine-containing polymer, exhibiting an oxygen gas permeability of 219 cm(STP)/(m·24 h·atm) or higher. This allows for the effective formation of three-dimensional tissue via cell culture.
Another notable patent is for a cell preparation aimed at treating cartilage tissue-related disorders. This invention offers a spheroid-containing cell preparation that demonstrates a high therapeutic effect for such disorders. The preparation contains cultured mesenchymal stem cells as an effective ingredient, making it a promising candidate for treatment.
Career Highlights
Throughout his career, Tomomi Makino has worked with reputable companies, including Nippon Shokubai Co., Ltd. and Hitachi Cable, Inc. His experience in these organizations has contributed to his expertise in the field of biotechnology and innovation.
Collaborations
Makino has collaborated with notable colleagues, including Kozo Tajiri and Takami Ushiwata. These partnerships have further enhanced his research and development efforts in the biotechnology sector.
Conclusion
Tomomi Makino's innovative work in cell culture technology and his impressive portfolio of patents highlight his significant impact on the field. His contributions are essential for advancing therapeutic solutions in tissue engineering and regenerative medicine.